Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07178314 · ClinicalTrials.gov registry record · NA
At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women
A NA study of Overactive Bladder, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT07178314: Recruiting NA study of Overactive Bladder, sponsored by Oregon Health and Science University.
NCT07178314 is a NA study of Overactive Bladder that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 38 participants, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07178314, a NA study of Overactive Bladder, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This study contains a mixed-methods design consisting of a single-arm, interventional study and prospective patient interviews evaluating a novel self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naïve overactive bladder (OAB) among rural-dwelling women. This study will be conducted in 3 rural Oregon communities where Oregon Health \& Science University satellite campuses are located.
Primary Outcome
A 13-item survey assessing health-related quality of life. Assessed on a scale from 1 to 100 with a higher score representing a better quality of life.
Conditions Studied
Interventions
- DEVICE Transcutaneous Tibial Nerve Stimulation (TTNS)
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2025-10-06 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07178314 shows while recruiting
NCT07178314 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 207-participant average among 46 other Overactive Bladder trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Tibial Nerve Stimulation (TTNS) is the first listed.
NCT07178314 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT07178314 about?
NCT07178314 is a clinical study titled "At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women". This study contains a mixed-methods design consisting of a single-arm, interventional study and prospective patient interviews evaluating a novel self-implemented at-home Transcutaneous Tibial Nerve Stimulation (TTNS) treatment protocol for management of treatment naïve overactive bladder (OAB) amon...
What is the current status of trial NCT07178314?
This trial is currently recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2025-10-06. Estimated completion is 2026-10.
What conditions does trial NCT07178314 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT07178314?
The interventions under investigation include: Transcutaneous Tibial Nerve Stimulation (TTNS) (DEVICE).
Who is sponsoring clinical trial NCT07178314?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07178314 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07178314's enrollment target sits among peer trials
38 34th of 46 higher than 13 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Percutaneous Nerve Evaluation Trial Time
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
RECRUITING · NA
-
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI